Risk Factors, Clinical Manifestations, and Treatment Outcomes of Primary Bone Sarcomas
Saudi Medical Journal · 2026
DOI: 10.15537/1658-3175.1009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Medical Journal, 2026. Verfasst von Ali H Alyami und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma, Sarcoma. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To investigate the risk factors, clinical manifestations, and treatment outcomes in patients with Primary Bone Sarcomas (PBS).
Methods
This retrospective study included all patients with PBS treated between June 2016 and December 2023 at King Abdulaziz Medical City, excluding patients with incomplete data, presence of other malignancies, diagnosis at autopsy, or unknown metastasis. Data were analyzed using SPSS software version 27. A p-value of less than 0.05 was considered statistically significant. Log Rank test was used for survival analysis Results: The study included 127 patients. Common past medical history included diabetes (7%), hypertension (5.5%), and metastasis at presentation (15%). Joint pain (76%) and bone swelling (75%) were common clinical presentations. The median overall survival was 5 years, with a 42% mortality rate. The presence of diabetes, hypertension, high Charlson score, high histological grading, and metastasis were more common among patients with osteosarcoma than other types (p < 0.05). Significant predictors of mortality included older age (HR: 1.03, p = 0.009), metastasis at presentation (HR: 8.19, p = 0.042), and metastasis (HR: 2.92, p = 0.010). Male gender (HR: 0.47, p = 0.020) had a lower risk of mortality.
Conclusion
This study highlights the significant burden of PBS in Saudi Arabia. Key risk factors such as age and metastasis at diagnosis significantly impact survival, underscoring the necessity for improved surveillance and follow-up strategies. Further research is needed to develop effective, risk-stratified treatment to improve outcomes for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Kingdom of Saudi Arabia.
- Department of Orthopedic Surgery, Ministry of the National Guard - Health Affairs, Jeddah, Kingdom of Saudi Arabia.
- King Abdullah International Medical Research Center, Jeddah, Kingdom of Saudi Arabia.
- Ministry of the National Guard-Health Affairs, King Abdulaziz Medical City, Jeddah, Kingdom of Saudi Arabia.
ORCID-Profile: Ali H Alyami, Mohammed A Alkhotani
Zitieren
APA
Alyami, A. H., Alkhotani, M. A., Alsiraihi, A. A., Bukhari, M. M., Alqurashi, A. S., Alghamdi, A. M., Kurdi, A. R., & Khawaji, B. A. (2026). Risk Factors, Clinical Manifestations, and Treatment Outcomes of Primary Bone Sarcomas. Saudi Medical Journal. https://doi.org/10.15537/1658-3175.1009
Vancouver
Alyami AH, Alkhotani MA, Alsiraihi AA, Bukhari MM, Alqurashi AS, Alghamdi AM, et al. Risk Factors, Clinical Manifestations, and Treatment Outcomes of Primary Bone Sarcomas. Saudi Medical Journal. 2026. doi:10.15537/1658-3175.1009
BibTeX
@article{Alyami2026,
author = {Alyami, Ali H and Alkhotani, Mohammed A and Alsiraihi, Abdulaziz A and Bukhari, Mohammed M and Alqurashi, Abdulrahman S and Alghamdi, Abdulrahman M and Kurdi, Anas R and Khawaji, Bader A},
title = {Risk Factors, Clinical Manifestations, and Treatment Outcomes of Primary Bone Sarcomas},
journal = {Saudi Medical Journal},
year = {2026},
doi = {10.15537/1658-3175.1009}
}
EUVIMED